Ixchel Scientific

Ixchel Scientific is developing diagnostics/prognostics to personalize cancer treatment regimens based on the physiology of an individual tumor.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Jose, CA, US
  • Currency USD
  • Founded January 2014
  • Employees 2
  • Website ixchelsci.com

Company Summary

The mission of Ixchel Scientific is to personalize cancer treatment based on the physiology of an individual tumor. Diagnostics/prognostics developed by Ixchel Scientific will allow oncologists to identify therapeutic regimens with low toxicity and high response rates for each patient.

Team

  • Founder & CEO

    Ph.D. in Molecular and Cell Biology with multifaceted expertise in various aspects of cancer biology, including, tumor microenvironment, tumor immunology, drug resistance, diagnostics/prognostics, target discovery, preclinical models and drug screening for efficacy testing.

  • Robert Tressler
    CSO

    Ph.D. in Biomedical Sciences with expertise in oncology R&D, in vitro and in vivo pharmacology, preclinical development, and FDA regulations with 22 years of experience holding leadership positions in pharmaceutical industry;

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free